We then assessed the prognostic impact of CAMK2B in 33 types of human tumors using GEPIA2 (12), and found that high expression of CAMK2B is associated with improved prognosis in KIRP, liver hepatocellular carcinoma (LIHC), and ovarian cancer (OV, Figure 3C, a). Here, CAMK2B is linked to ovarian cancer.